Skip to content
Search

Latest Stories

Drug deaths in Scotland soar to record, minister calls it “heart-breaking”

Drugs Policy Minister Angela Constance described the increase in drug-related deaths as “heart-breaking”, and reiterated the Scottish government’s determination to continue its work to address the crisis.

National Records of Scotland, the statistics agency, today (30) reported a 5 per cent on-year increase in the drugs-related fatalities in 2020 to 1,339 deaths. The figure indicated the highest figure on record and the seventh annual increase in a row.


After the appointment of Constance in December 2020 to the newly created post of Drugs Policy Minister, a national mission on the crisis was announced in January.

Since then the Scottish government has announced to spend £250 million to address the crisis over the next five years.

Starting September, the agency will release quarterly reports of suspected drug deaths to enable better surveillance and response from all those involved in tackling this public health emergency.

“We need to gather as much information as we can about drug use in Scotland and to that end, data on suspected drug deaths will be published quarterly from this September. This will ensure we can react more quickly and effectively to this crisis and identify any emerging trends,” Constance said.

“We are working hard to get more people into the treatment that works for them as quickly as possible. Without treatment, there is little hope of recovery so we are funding as many community and third sector initiatives as we can so that individuals have the widest possible choice and can opt for the support which suits them and their family.

“Of the £250 million announced over the next five years, £100 million will go on improving the provision of residential rehabilitation and I will update Parliament on progress in this area after the summer recess,” she said.

Drug Deaths Taskforce Chair Professor Catriona Matheson said: “Every drug-related death in Scotland is an avoidable tragedy, and these figures serve to remind us of the importance and urgency of our mission to identify the areas of action that can make a sustainable impact against the challenge.”

Responding to the data, Laura Wilson, RPS Scotland Policy and Practice Lead, said: “It’s concerning that drug related deaths and hospital admissions continue to rise in Scotland.  Many of these deaths are preventable.

“Pharmacists, and pharmacy teams, already play a big role in supporting and providing treatment to people who use drugs, as well as offering harm reduction services and advice. The RPS wants to build on this fantastic work by enabling them to do even more to reduce harm from drugs.”

“We are calling on the Scottish government, pharmacy organisations, contractors and members of the profession to work together to reduce harm from drugs and improve the health of people who use drugs. We are also asking for significant resource, expertise and finance to be made available,” she said.

The Scottish first minister Nicola Sturgeon said the record was “shameful”, and promised concerted action.

Sturgeon said on Twitter, “The number of lives lost to drugs is unacceptable, each one a human tragedy. @scotgov does not shirk the responsibility and we are determined to make changes that will save lives.

“Today, my thoughts are with every family who has lost a loved one – I am sorry for the loss you have suffered. However, I know [that] what is required isn’t words, but action to prevent people dying, and that is what we are determined to deliver.”

In June, RPS Scotland had published a policy document on pharmacy’s role in reducing drug harms and preventing drug deaths.

The report made 14 recommendations including:

  • Naloxone must be available from every community pharmacy and staff trained to use it.
  • All pharmacists should have access to shared patient records and clear communication pathways with other health care professionals involved in the care of people who use drugs.
  • Regulated Supervised Drug Consumption Rooms (SDCRs) should be introduced and use of Heroin Assisted Treatment (HAT) should be expanded as treatment options with pharmacy input from the start.

More For You

AAH Pharmaceuticals introduces 20 new electric vans to its delivery fleet

18 vans have been added to the AAH DC in Ruislip, and another 2 to their branch in Glasgow

Photo credit: AAH

AAH Pharmaceuticals adds 20 new electric vans to reduce carbon emissions

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced 20 new electric vans to its delivery fleet, marking a significant step forward in its Carbon Reduction Plan, which is aligned to the NHS net zero targets.

Eighteen of the new electric vehicles have been deployed at the AAH distribution centre in Ruislip, with the remaining two now in operation at its Glasgow branch.

Keep ReadingShow less
Numark launches new digital consultation platform to support independent prescribers

Harry McQuillan, Chairman of Numark

Numark launches DigiPharma to empower independent prescribers

Numark has launched a new digital consultation platform, called DigiPharma, designed to support both current and future independent prescribers (IPs) in making full use of their qualifications.

The revolutionary cloud-based prescribing recording platform is now available exclusively to Numark members.

Keep ReadingShow less
Operation Subaru:

Some of the medicines seized in raids today. Credit: MHRA

12 arrested in MHRA’s biggest medicines trafficking crackdown

Twelve people have been arrested in a series of dawn raids across the West Midlands and the Northwest of England today (29 April), as part of the biggest criminal investigation ever undertaken by the Medicines and Healthcare products Regulatory Agency (MHRA) into organised medicines trafficking.

The suspects were detained on suspicion of involvement in organised crime, conspiracy to sell or supply controlled and unlicensed medicines, and money laundering.

Keep ReadingShow less
Sukhi Basra named NPA vice-chair in historic leadership update with Olivier Picard as new chair

Olivier Picard steps up as NPA chair, Basra as vice-chair

Olivier Picard named new NPA chair

The National Pharmacy Association (NPA) has announced Olivier Picard as the organisation’s new chair.

Picard replaces Nick Kaye whose term comes to an end this week.

Keep ReadingShow less
 RPS honours Professor Tony Avery OBE for excellence in prescribing safety and patient care

Professor Tony Avery OBE

Pic credit: RPS

Professor Tony Avery OBE awarded RPS Honorary Fellowship

The Royal Pharmaceutical Society (RPS) Assembly has awarded an Honorary Fellowship to Professor Tony Avery OBE in recognition of his outstanding contribution to prescribing safety and patient care.

The Honorary Fellowship is given to those who are not eligible for membership of the Society but have either attained a distinction in a particular aspect or aspects of pharmacy, made a distinctive contribution to pharmacy or the RPS, distinguished themselves in any branches of knowledge referred to in the objects of the Society or achieved eminence in public life.

Keep ReadingShow less